Active substance
Results for the substance selexipag
9 results
About this active substance
Selexipag is a medication used for the treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity and delay disease progression. It acts as a prostacyclin receptor agonist, relaxing blood vessels in the lungs and reducing pulmonary arterial pressure.
The medication is taken orally, as directed by a doctor, usually twice daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as headache, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.
Common side effects include headache, nausea, and diarrhea. In rare cases, severe reactions such as hypotension or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, as directed by a doctor, usually twice daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor the response to therapy.
Patients should be aware of potential side effects, such as headache, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.
Common side effects include headache, nausea, and diarrhea. In rare cases, severe reactions such as hypotension or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
-
-
UPTRAVI 1200mcg film-coated tablets CILAG ORIGINAL MEDICINE
-
UPTRAVI 1600mcg film-coated tablets CILAG ORIGINAL MEDICINE
-
UPTRAVI 600mcg film-coated tablets CILAG ORIGINAL MEDICINE
-
UPTRAVI 1400mcg film-coated tablets CILAG ORIGINAL MEDICINE
-
UPTRAVI 400mcg film-coated tablets CILAG ORIGINAL MEDICINE
-
UPTRAVI 1000mcg film-coated tablets CILAG ORIGINAL MEDICINE
-
UPTRAVI 800mcg film-coated tablets CILAG ORIGINAL MEDICINE
-
UPTRAVI 200mcg film-coated tablets CILAG ORIGINAL MEDICINE